About: Bernard Zinman

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Bernard Zinman Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Canadian endocrinologist

Attributes	Values
rdf:type	Item
description	연구원 (ko) 研究者 (ja) изилдөөчү (ky) 研究者 (zh) onderzoeker (nl) Canadian endocrinologist (en)
rdfs:label	Bernard Zinman (en) Bernard Zinman (es) Bernard Zinman (fr) Bernard Zinman (it) Bernard Zinman (nl) Bernard Zinman (ast)
skos:prefLabel	Bernard Zinman (en) Bernard Zinman (es) Bernard Zinman (fr) Bernard Zinman (it) Bernard Zinman (nl) Bernard Zinman (ast)
name	Bernard Zinman (en) Bernard Zinman (es) Bernard Zinman (fr) Bernard Zinman (it) Bernard Zinman (nl) Bernard Zinman (ast)
given name	wds:Q61337175-4A770393-4F46-4A5C-B3B3-BE7DF6A401D6
given name	Bernard
instance of	wds:Q61337175-BFB4B6EF-B9C1-4BE4-9873-0ECBFD422F29
instance of	Homo sapiens
Google Knowledge Graph ID	wds:Q61337175-5320C293-CACF-4FDB-B3EB-AD6E77CC880A
Order of Canada recipient ID	wds:Q61337175-30C7BBCB-5304-445A-87DE-6ACC359FA02C
Google Knowledge Graph ID	http://g.co/kg/g/11f017p6bn
Google Knowledge Graph ID	/g/11f017p6bn
Order of Canada recipient ID	146-1374
occupation	wds:Q61337175-7028254E-E82A-4B74-9145-5C0C7667B4DC
sex or gender	wds:Q61337175-f891151b-47d2-4333-8307-97f18e1ddb7b
ISNI	wds:Q61337175-ec3c4d9c-459f-b352-b3aa-560528694560
VIAF ID	wds:Q61337175-46b7d37e-4423-2baa-edbb-794a14ee0880
Library of Congress authority ID	wds:Q61337175-39d3bc9b-4b8b-9e62-4acd-ba18a3ab8a90
WorldCat Identities ID (superseded)	wds:Q61337175-0EE2CEC2-77CA-4616-8F01-3A504F6C289C
National Library of Israel J9U ID	wds:Q61337175-1F0F9738-D8AE-4B03-A448-832037123FAF
National Library of Israel ID (old)	wds:Q61337175-26576bdb-4696-3def-d796-66b4664f1251
VIAF ID	http://viaf.org/viaf/103320465
Library of Congress authority ID	http://id.loc.gov/authorities/names/n78067135
occupation	researcher
sex or gender	male
ISNI	0000000385230798
VIAF ID	103320465
Library of Congress authority ID	n78067135
WorldCat Identities ID (superseded)	lccn-n78067135
National Library of Israel J9U ID	987007342334205171
National Library of Israel ID (old)	004319505
ORCID iD	wds:Q61337175-59225527-B44D-43E1-B884-FAB39740C106
ORCID iD	https://orcid.org/0000-0002-0041-1876
ORCID iD	0000-0002-0041-1876
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q61337175 Bernard Zinman
is author of	ACE-I and ARBs in early diabetic nephropathy Changes in diabetes self-care behaviors make a difference in glycemic control: the Diabetes Stages of Change (DiSC) study Prospective association of 25(OH)D with metabolic syndrome Vitamin D status and cardiometabolic assessment in infancy Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes SGLT-2 inhibitors and cardiovascular risk: proposed pathways and review of ongoing outcome trials Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: rationale for the active-comparator CAROLINA trial Methylenetetrahydrofolate reductase polymorphism 677C>T is associated with peripheral arterial disease in type 2 diabetes Complications of Type 2 Diabetes Among Aboriginal Canadians: prevalence and associated risk factors Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications cohort Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: update regarding thiazolidinediones: a consensus statement from the American Diabetes Association and the European Association for th Association of parity with risk of type 2 diabetes and related metabolic disorders Rosiglitazone decreases C-reactive protein to a greater extent relative to glyburide and metformin over 4 years despite greater weight gain: observations from a Diabetes Outcome Progression Trial (ADOPT) Effect of short-term intensive insulin therapy on quality of life in type 2 diabetes Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long) Risk of early progression to prediabetes or diabetes in women with recent gestational dysglycaemia but normal glucose tolerance at 3-month postpartum Glucagon response to oral glucose challenge in type 1 diabetes: lack of impact of euglycemia. Renal and retinal effects of enalapril and losartan in type 1 diabetes Effect of protein kinase Cbeta inhibition on renal hemodynamic function and urinary biomarkers in humans with type 1 diabetes: a pilot study A single nucleotide polymorphism in protein tyrosine phosphatase PTP-1B is associated with protection from diabetes or impaired glucose tolerance in Oji-Cree Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD). Association between 7 years of intensive treatment of type 1 diabetes and long-term mortality Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisited The effect of intensive glycemic treatment on coronary artery calcification in type 1 diabetic participants of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Administrative data algorithms can describe ambulatory physician utilization Prevention or delay of type 2 diabetes A diabetes outcome progression trial (ADOPT): an international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes Impaired fasting glucose and impaired glucose tolerance: implications for care Changes over time in glycemic control, insulin sensitivity, and beta-cell function in response to low-dose metformin and thiazolidinedione combination therapy in patients with impaired glucose tolerance Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trials. Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT). Nontraditional cardiovascular risk factors in pediatric metabolic syndrome Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes Determinants of reversibility of β-cell dysfunction in response to short-term intensive insulin therapy in patients with early type 2 diabetes Changes in prandial glucagon levels after a 2-year treatment with vildagliptin or glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis Circadian variation in the response to the glucose challenge test in pregnancy: implications for screening for gestational diabetes mellitus Patient age, ethnicity, medical history, and risk factor profile, but not drug insurance coverage, predict successful attainment of glycemic targets: Time 2 Do More Quality Enhancement Research Initiative (T2DM QUERI) Diabetes mellitus and breast cancer: a retrospective population-based cohort study.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software